CellectGen

Cellect Gen

Medical Devices, 2265 E Foothill BLVD, Pasadena, California, 91107, United States, 1-10 Employees

cellectgen.com

  • LinkedIn

Who is CELLECTGEN

CellectGens mission is to develop user-friendly, saliva-based POC platform technologies to help dentists identify patients with high risk of emerging active disease lesions in less than 1...

Read More

map
  • 2265 E Foothill BLVD, Pasadena, California, 91107, United States Headquarters: 2265 E Foothill BLVD, Pasadena, California, 91107, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2835

checked-icon Does something look wrong? Fix it. | View contact records from CELLECTGEN

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding CellectGen

Answer: CellectGen's headquarters are located at 2265 E Foothill BLVD, Pasadena, California, 91107, United States

Answer: CellectGen's official website is https://cellectgen.com

Answer: CellectGen's revenue is Under $1 Million

Answer: CellectGen's SIC: 2835

Answer: CellectGen has 1-10 employees

Answer: CellectGen is in Medical Devices

Answer: CellectGen contact info: Phone number: Website: https://cellectgen.com

Answer: CellectGens mission is to develop user-friendly, saliva-based POC platform technologies to help dentists identify patients with high risk of emerging active disease lesions in less than 15 minutes. The screening test is as easy as 1-2-3, and unlike current clinical methods, it can be done by anyone from the comforts of home. The technology is based on integrated components consisting of: Saliva collection Lateral flow based test - Our next generation point-of-care testing technology allows for detection, and measurement of levels of specific biomarkers of bone and soft tissue destruction to estimate the status of active disease in patients. Mobile application - Our mobile app quantifies results and guides treatment in real-time more accurately, more easily, and cost-effectively than current existing methods, thus permitting patients to save their natural teeth. The app will not only increase the accuracy of the test by quantifying the results and eliminating the dentists reliance on visual assessments, but also expand access to data and trends on each patient, digitally. Our products represent the next generation solutions, designed to improve early detection and prevention of dental implant failure and gum disease in the 64.7 million individuals who suffer from various forms of the disease

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access